Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association
|
July 1, 1996
Total incontinence secondary to sphincter destruction after prostate cryotherapy for recurrent prostatic carcinoma
T Watanabe, D A Rivas, M Miettinen, et al.
Radiology
|
November 1, 1993
Clinical and US findings in prostate cancer: patients with normal prostate-specific antigen levels
J A Spencer, A A Alexander, L Gomella, et al.
Cancer Research
|
March 1, 1993
Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1
Z Pietrzkowski, G Mulholland, L Gomella, et al.
Clinical Radiology
|
October 1, 1994
Ultrasound-guided four quadrant biopsy of the prostate: efficacy in the diagnosis of isoechoic cancer
J A Spencer, A A Alexander, L Gomella, et al.
Urology
|
June 4, 1998
Stage T3 prostate cancer: a nonrandomized comparison between definitive irradiation and induction hormonal manipulation plus prostatectomy
B W Corn, R K Valicenti, S G Mulholland, et al.
Seminars in Oncology
|
October 1, 1995
Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer
G R Hudes, F E Nathan, C Khater, et al.
Urology
|
February 1, 1995
Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection
J T Bishoff, A Reyes, I M Thompson, et al.
The Journal of Urology
|
November 1, 1989
Clinically occult Leydig cell tumor presenting with gynecomastia
G P Haas, S Pittaluga, L Gomella, et al.
The Journal of Urology
|
January 1, 1997
Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder
E M Rosen, A Joseph, L Jin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 1997
Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer
G R Hudes, F Nathan, C Khater, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
International Journal of Urology : Official Journal of the Japanese Urological Association
|
July 1, 1996
Total incontinence secondary to sphincter destruction after prostate cryotherapy for recurrent prostatic carcinoma
T Watanabe, D A Rivas, M Miettinen, et al.
Radiology
|
November 1, 1993
Clinical and US findings in prostate cancer: patients with normal prostate-specific antigen levels
J A Spencer, A A Alexander, L Gomella, et al.
Cancer Research
|
March 1, 1993
Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1
Z Pietrzkowski, G Mulholland, L Gomella, et al.
Clinical Radiology
|
October 1, 1994
Ultrasound-guided four quadrant biopsy of the prostate: efficacy in the diagnosis of isoechoic cancer
J A Spencer, A A Alexander, L Gomella, et al.
Urology
|
June 4, 1998
Stage T3 prostate cancer: a nonrandomized comparison between definitive irradiation and induction hormonal manipulation plus prostatectomy
B W Corn, R K Valicenti, S G Mulholland, et al.
Seminars in Oncology
|
October 1, 1995
Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer
G R Hudes, F E Nathan, C Khater, et al.
Urology
|
February 1, 1995
Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection
J T Bishoff, A Reyes, I M Thompson, et al.
The Journal of Urology
|
November 1, 1989
Clinically occult Leydig cell tumor presenting with gynecomastia
G P Haas, S Pittaluga, L Gomella, et al.
The Journal of Urology
|
January 1, 1997
Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder
E M Rosen, A Joseph, L Jin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 1997
Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer
G R Hudes, F Nathan, C Khater, et al.
Page
of 2